Sun Pharmaceutical
 |
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (April 2011) |
 |
|
| Type | Public |
|---|---|
| Traded as | BSE: 524715 BSE SENSEX Constituent |
| Industry | Pharmaceuticals |
| Genre | Generic Pharma Company |
| Founded | Mumbai, India 1983 |
| Founder(s) | Dilip Shanghvi |
| Headquarters | Mumbai, India |
| Key people | Dilip Shanghvi (Chairman and MD) |
| Products | Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health |
| Revenue |   6,079 crore (US$1.34 billion) (2011)[1] |
| Net income | 1,816 crore (US$399.52 million) (2011) |
| Employees | 11,200 (2011) |
| Website | www.sunpharma.com |
Sun Pharmaceutical Industries Ltd. is an international pharmaceutical company based in Mumbai, India. It should not be confused with Sun Pharmaceuticals Corp, a manufacturer of sun care products owned by the Playtex branch of Energizer Holdings.
Sun Pharmaceutical, often known just as Sun Pharma, makes many generic and brand name drugs that are distributed in the United States, Europe, Asia and worldwide.[2]
Contents |
[edit] Acquisition of Taro Pharmaceuticals
A planned acquisition of Israeli Taro Pharmaceuticals initiated in March 2007 completed in Sept 2010.[3][4] Taro has a strong franchise in dermatology and topical products, in addition to product baskets in cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. Taro US has more than 100 ANDA drug approvals in the U.S. alone. One NDA as well as 26 ANDA are awaiting with the USFDA.[5]
[edit] Raids by USFDA
On 25 June 2009, US Marshals seized 33 drugs made by Caraco, the subsidiary of Sun Pharma. The seizure was due to the noncompliance of Caraco with the Current good manufacturing practice (cGMP) requirements of the U.S. Food and Drug Administration (USFDA). The seizure was followed by an 18% drop in price of Sun Pharma.[6]
[edit] References
- ^ http://www.bseindia.com/bseplus/StockReach/AdvanceStockReach.aspx?scripcode=524715
- ^ Sun Pharmaceutical Industries Ltd. (SUN.BO): Stock Quote & Company Profile - BusinessWeek
- ^ staff (2007-06-15). "Sun Takes Over Taro for $454M" (print). Genetic Engineering & Biotechnology News (Mary Ann Liebert, Inc.): p. 10.
- ^ "Taro has a strong franchise in dermatology and topical products, in addition to product baskets in cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. Taro US has more than 100 ANDA drug approvals in the U.S. alone. One NDA as well as 26 ANDA are awaiting with the USFDA." (Press release). Taro Pharmaceuticals. 2008-05-28. http://phx.corporate-ir.net/phoenix.zhtml?c=114698&p=irol-newsArticle&ID=1151068&highlight=. Retrieved 2008-07-06.
- ^ Completed acquisition of Taro Pharmaceuticals. Sun Pharmaceuticals. 2011-07-04. http://www.sunpharma.com/Acquisition.do. Retrieved 2011-07-04.
- ^ St hammers Sun Pharma as USFDA seizes 33 drugs of arm
